Additionally, disruption of signalling through a HRG/HER3 autocrine loop in ovarian cancer cells, by RNAi targeting either HRG or HER3, has been shown to successfully reduce proliferation of the investigated cell lines [33]. The gene discussed is ERBB3; the disease is ovarian carcinoma.